
Number of publications published per year by Nosotti, Lorenzo. (Source : PubMed)

Distribution of publications types for Nosotti, Lorenzo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial.
BMC Gastroenterol
2010;10
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study.
Eur J Public Health
2009

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.
Liver Int.
2009;29;10

The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
Dig Liver Dis
2009;41;11


A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B.
Antivir. Ther. (Lond.)
2009;14;8
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Clin Ther
2008;30;2

Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant.
J. Infect.
2007;54;4
[ See timeline ] [ See all publications ]
means that Nosotti, Lorenzo has 3 papers cited a least 3 times - methodology
Department of Internal Medicine and Liver Unit, Marino Hospital, Rome, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.